Jamil Beg - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Jamil Beg’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
fir***@***.com
Available after registration.
Markets
Past investmentsJamil Beg is a Venture Capital, Investor based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as Precision NanoSystem, Vor Biopharma, Aprea, Arvinas, GenePeeks, Renasant Bio, RareCytePortal Instruments, Entrada Therapeutics, AdvanCell, Ceterix Orthopaedics, Audentes Therapeutics, CinCor Pharma, Homology Medicines, Cabaletta Bio, Flexion Therapeutics, Nido Biosciences, Expansion Therapeutics, Spyryx Biosciences, Ensoma, Cleave Therapeutics, Nohla Therapeutics, scPharmaceuticals, Wildcat Discovery Technologies, Scientist.com, Relypsa, Purigen Biosystems, Epirus Biopharmaceuticals, Rallybio, Pulmatrix, Crinetics Pharmaceuticals, NodThera, Kinaset Therapeutics, Calibrium, Inipharm, Aprea AB, Kinestral Technologies, Magnetic Insight, TMRW Life Sciences, Pearl Therapeutics, Chrono Therapeutics, Impel NeuroPharma, Igenica, Nouscom, Novira Therapeutics, Bird Rock Bio, Viveve, Enliven Therapeutics, Millendo Therapeutics, Pear Therapeutics, Achaogen, Escient Pharmaceuticals, Artiva Biotherapeutics, Cidara Therapeutics, Akouos, Bellerophon Therapeutics, IDEAYA Biosciences, BlueLight Therapeutics, SAGE Therapeutics, Neurogastrx, Novome Biotechnologies, . Over time, Jamil Beg has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Jamil Beg is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Life Science, Software, Biotechnology, Genomics, Digital Health, Medical, Therapeutics, Emergency Medicine, Pharmaceuticals may find it worthwhile to explore potential connections with Jamil Beg, as their portfolio suggests a familiarity and interest in this area.
Understanding Jamil Beg’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
